Viral hepatitis among drug users in methadone maintenance: Associated factors, vaccination outcomes, and interventions

David C. Perlman, Ashly E. Jordan, Courtney McKnight, Christopher Young, Kevin L. Delucchi, James L. Sorensen, Don C. Des Jarlais, Carmen L. Masson

Research output: Contribution to journalArticlepeer-review

Abstract

Drug users are at high risk of viral Hepatitis A, B, and C. The prevalence of Hepatitis A, Hepatitis B, and Hepatitis C, associated factors, and vaccine seroconversion among drug treatment program participants in a randomized controlled trial of hepatitis care coordination were examined. Of 489 participants, 44 and 47% required Hepatitis A/Hepatitis B vaccinations, respectively; 59% were Hepatitis C positive requiring linkage to care. Factors associated with serologic statuses, and vaccine seroconversion are reported; implications for strategies in drug treatment settings are discussed. Results suggest generalizable strategies for drug treatment programs to expand viral hepatitis screening, prevention, vaccination, and linkage to care.

Original languageEnglish (US)
Pages (from-to)322-331
Number of pages10
JournalJournal of Addictive Diseases
Volume33
Issue number4
DOIs
StatePublished - Oct 2 2014

Keywords

  • Hepatitis C
  • Viral hepatitis
  • methadone maintenance treatment program
  • vaccination

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Viral hepatitis among drug users in methadone maintenance: Associated factors, vaccination outcomes, and interventions'. Together they form a unique fingerprint.

Cite this